BCIQ Profiles

Company Profile Report

FDA approves cUTI combo Vabomere from MDCO

FDA approved Vabomere meropenem/vaborbactam (Carbavance) from The Medicines Co. (NASDAQ:MDCO) to treat adults with complicated urinary tract infections

Read the full 188 word article

How to gain access

Continue reading with a
two-week free trial.